<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ACC</journal-id>
<journal-id journal-id-type="hwp">spacc</journal-id>
<journal-title>European Heart Journal: Acute Cardiovascular Care</journal-title>
<issn pub-type="ppub">2048-8726</issn>
<issn pub-type="epub">2048-8734</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/2048872612453922</article-id>
<article-id pub-id-type="publisher-id">10.1177_2048872612453922</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Arrhythmias</subject>
<subj-group subj-group-type="heading">
<subject>Original scientific paper</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>QRS fragmentation in patients with arrhythmogenic right ventricular cardiomyopathy and complete right bundle branch block: a risk stratification</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Peters</surname><given-names>Stefan</given-names></name>
</contrib>
<aff id="aff1-2048872612453922">St Antonius-Hospital Gronau, Gronau, Germany</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-2048872612453922">Stefan Peters, St Antonius-Hospital Gronau, Möllenweg 22, 48599 Gronau, Germany. Email: <email>H.u.S.Peters@t-online.de</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>9</month>
<year>2012</year>
</pub-date>
<volume>1</volume>
<issue>3</issue>
<fpage>236</fpage>
<lpage>239</lpage>
<history>
<date date-type="received">
<day>10</day>
<month>2</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>6</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© The European Society of Cardiology 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">European Society of Cardiology</copyright-holder>
</permissions>
<abstract>
<sec id="section1-2048872612453922">
<title>Background:</title>
<p>Patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) and complete right bundle branch block (RBBB) very often have recurrent ventricular tachycardia and develop biventricular heart failure in the follow up, requiring heart transplantation and/or diuretics. In other patients with ARVC/D excluding RBBB, QRS fragmentation in the S wave of right precordial leads identifies patients with recurrent ventricular tachycardia, primary ventricular fibrillation, and recurrent implantable cardioverter defibrillator discharges; QRS fragmentation ≥3 leads characterized patients who died from sudden cardiac death.</p>
</sec>
<sec id="section2-2048872612453922">
<title>Method:</title>
<p>In a cohort of 374 patients with ARVC/D (208 males; mean±SD age 46.5±14.8 years), there were 22 patients with complete RBBB: 17 patients with ARVD/C developed complete RBBB and had biventricular heart failure in a follow up of 4–6 years. In five patients with ARVC/D, complete RBBB was initially evident. In all patients with ARVC/D and RBBB, QRS fragmentation ≥3 of all 12 ECG leads and QRS fragmentation in the S wave of right precordial leads were analysed.</p>
</sec>
<sec id="section3-2048872612453922">
<title>Results:</title>
<p>QRS fragmentation ≥3 of all 12 ECG leads and in the S wave of right precordial leads were present in 16/17 patients who developed RBBB and none of the five patients with initial RBBB. In one patient with initial RBBB, QRS fragmentation ≥3 leads was present (<italic>r</italic>=17.45; <italic>p</italic>&lt;0.0001).</p>
</sec>
<sec id="section4-2048872612453922">
<title>Conclusion:</title>
<p>Patients with recurrent ventricular tachycardia who develop biventricular heart failure requiring heart transplantation and/or diuretics are characterized by QRS fragmentation in the S wave of right precordial leads and ≥3 of all 12 ECG leads. These results are statistically significant. Patients with initial RBBB have an overall benign prognosis.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Biventricular heart failure</kwd>
<kwd>QRS fragmentation</kwd>
<kwd>recurrent ventricular tachycardia</kwd>
<kwd>right bundle branch block</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section5-2048872612453922" sec-type="intro">
<title>Introduction</title>
<p>The development of complete right bundle branch block (RBBB) in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a not-so-rare event. Patients with ARVC/D and RBBB have a poor prognosis with recurrent ventricular tachycardia and development of severe biventricular heart failure later on.<sup><xref ref-type="bibr" rid="bibr1-2048872612453922">1</xref></sup> Some patients require heart transplantation. All patients with symptoms of biventricular heart failure were treated with angiotensin-converting enzyme inhibitors, beta blockers, and diuretics. In 2008, QRS fragmentation were detected as a diagnostic marker of ARVC/D<sup><xref ref-type="bibr" rid="bibr2-2048872612453922">2</xref></sup> and in 2011 QRS fragmentation were described as a prognostic marker<sup><xref ref-type="bibr" rid="bibr3-2048872612453922">3</xref></sup> of arrhythmic events (recurrent ventricular tachycardia, primary ventricular fibrillation, recurrent implantable cardioverter defibrillator discharges and sudden cardiac death).</p>
<p>QRS fragmentation was used to characterize patients with ARVC/D and RBBB who have a poor prognosis and develop biventricular heart failure after years as a risk stratification.</p>
</sec>
<sec id="section6-2048872612453922" sec-type="methods">
<title>Method</title>
<p>In a cohort of 374 patients with modified diagnostic criteria of ARVC/D<sup><xref ref-type="bibr" rid="bibr4-2048872612453922">4</xref></sup> with a mean±SD age of 46.5±14.8 years (208 males), there were 22 patients (6%) who fulfilled the diagnostic criteria of complete RBBB. In these 22 patients, QRS fragmentation should be detected at standard 12 lead ECG writing at a paper speed of 50 mm/s and 10 mm/mV amplitude technique.</p>
<p>Of these 22 patients, there were 17 patients with recurrent ventricular tachycardia who developed biventricular heart failure in the follow up and five patients with complete RBBB when the diagnosis was made and a stable clinical course in a follow up of 4–6 years.</p>
<p>QRS fragmentation in the S wave of right precordial leads and QRS fragmentation in ≥3 leads were used.</p>
</sec>
<sec id="section7-2048872612453922" sec-type="results">
<title>Results</title>
<p>In all patients with ARVC/D and complete RBBB, QRS fragmentation were present with 2.4±1.8 leads involved in a range of 1–7.</p>
<p>QRS fragmentation ≥3 of all 12 ECG leads and in the S wave of right precordial leads were present in 16/17 patients who developed RBBB and biventricular heart failure and none of the five patients with initial RBBB. In one patient with RBBB right from the beginning, QRS fragmentation ≥3 leads was present (<italic>r</italic>=17.45; <italic>p</italic>&lt;0.0001). <xref ref-type="fig" rid="fig1-2048872612453922">Figure 1</xref> shows an example of a patient with recurrent ventricular tachycardia and developing heart failure. <xref ref-type="fig" rid="fig2-2048872612453922">Figure 2</xref> shows an example of a patient with no sustained ventricular tachycardia and no heart failure.</p>
<fig id="fig1-2048872612453922" position="float">
<label>Figure 1.</label>
<caption><p>ECG of a patient with recurrent ventricular tachycardia and developing heart failure</p>
<p>QRS fragmentation is present in more than 3 leads.</p></caption>
<graphic xlink:href="10.1177_2048872612453922-fig1.tif"/></fig>
<fig id="fig2-2048872612453922" position="float">
<label>Figure 2.</label>
<caption><p>ECG of a patient with no ventricular tachycardia and no heart failure</p>
<p>QRS fragmentation is present in less than 3 leads.</p></caption>
<graphic xlink:href="10.1177_2048872612453922-fig2.tif"/></fig>
</sec>
<sec id="section8-2048872612453922" sec-type="discussion">
<title>Discussion</title>
<p>In patients with complete RBBB and ARVC/D, QRS fragmentation was more prevalent in comparison with other patients with complete RBBB.<sup><xref ref-type="bibr" rid="bibr5-2048872612453922">5</xref></sup> It is also known, that patients who develop complete RBBB often have biventricular heart failure in follow up.<sup><xref ref-type="bibr" rid="bibr1-2048872612453922">1</xref>,<xref ref-type="bibr" rid="bibr6-2048872612453922">6</xref></sup></p>
<p>For the first time, it is possible to make a risk management for those patients who develop complete RBBB and biventricular heart failure. These patients have recurrent ventricular tachycardia and ECG without conduction delay with epsilon potentials,<sup><xref ref-type="bibr" rid="bibr7-2048872612453922">7</xref></sup> T wave inversions in right precordial leads,<sup><xref ref-type="bibr" rid="bibr8-2048872612453922">8</xref></sup> and terminal activation delay.<sup><xref ref-type="bibr" rid="bibr9-2048872612453922">9</xref></sup> In a follow up of at least 4 up to 6 years, these patients develop complete RBBB and later on biventricular heart failure, requiring heart transplantation in some cases. These patients are treated with angiotensin-converting enzyme inhibitors, beta blocking agents, and diuretics.</p>
<p>A diagnosis of complete RBBB predicts a worse outcome of patients with arrhythmogenic right ventricular cardiomyopathy. Out of 22 patients with complete RBBB, 17 developed severe biventricular heart failure, making heart transplantation and diuretic therapy necessary. This was particularly true for patients who developed complete RBBB. In 16 patients, QRS fragmentation in the S wave of right precordial leads and in ≥3 leads were present. Four patients who had complete RBBB from the very beginning had a benign prognosis. In one patient, QRS fragmentation ≥3 leads other than in the S wave of right precordial leads was present and the prognosis of the patient was uneventful.</p>
<p>If a patient with ARVC/D develops complete RBBB, the patient must be treated with an implantable cardioverter defibrillator and aggressive anti-failure agents.</p>
<p>In conclusion, for the first time, QRS fragmentation has been shown to help to predict the development of heart failure of patients with complete RBBB. Due to a low rate of patients with complete RBBB, these results are questionable and must be assessed in larger multicentre studies. In healthy volunteers, complete RBBB can be diagnosed in about 3%,<sup><xref ref-type="bibr" rid="bibr10-2048872612453922">10</xref></sup> but a complete RBBB in 6% of cases with ARVC/D is not enough to make the results or the study more relevant.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-2048872612453922">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Peters</surname><given-names>S</given-names></name>
<name><surname>Trümmel</surname><given-names>M</given-names></name>
<name><surname>Koehler</surname><given-names>B</given-names></name>
</person-group>. <article-title>Special features of right bundle branch block in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia</article-title>. <source>Int J Cardiol</source> <year>2012</year>; <volume>157</volume>: <fpage>102</fpage>–<lpage>103</lpage>.</citation>
</ref>
<ref id="bibr2-2048872612453922">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Peters</surname><given-names>S</given-names></name>
<name><surname>Trümmel</surname><given-names>M</given-names></name>
<name><surname>Koehler</surname><given-names>B</given-names></name>
</person-group>. <article-title>QRS fragmentation as a diagnostic marker of arrhythmogenic right ventricular dysplasia-cardiomyopathy</article-title>. <source>Heart Rhythm</source> <year>2008</year>; <volume>5</volume>: <fpage>1417</fpage>–<lpage>1421</lpage>.</citation>
</ref>
<ref id="bibr3-2048872612453922">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Peters</surname><given-names>S</given-names></name>
<name><surname>Trümmel</surname><given-names>M</given-names></name>
<name><surname>Koehler</surname><given-names>B</given-names></name>
</person-group>. <article-title>Prognostic value of QRS fragmentation in patients with arrhythmogenic right ventricular cardiomyopathy</article-title>. <source>J Cardiovasc Med</source> <year>2012</year>; <volume>13</volume>: <fpage>295</fpage>–<lpage>298</lpage>.</citation>
</ref>
<ref id="bibr4-2048872612453922">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marcus</surname><given-names>FI</given-names></name>
<name><surname>McKenna</surname><given-names>WJ</given-names></name>
<name><surname>Sherrill</surname><given-names>D</given-names></name>
<etal/>
</person-group>. <article-title>Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Proposed modification of the Task Force Criteria</article-title>. <source>Eur Heart J</source> <year>2010</year>; <volume>31</volume>: <fpage>806</fpage>–<lpage>814</lpage>.</citation>
</ref>
<ref id="bibr5-2048872612453922">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>L</given-names></name>
<name><surname>Wu</surname><given-names>R</given-names></name>
<name><surname>Zareba</surname><given-names>W</given-names></name>
<etal/>
</person-group>. <article-title>Right bundle branch block: the morphology differences between patients with and without arrhythmogenic right ventricular dysplasia</article-title>. <source>Heart Rhythm</source> <year>2011</year> (<supplement>Supplement</supplement>); <volume>8</volume>: <fpage>P04</fpage>–<lpage>P141</lpage>.</citation>
</ref>
<ref id="bibr6-2048872612453922">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Peters</surname><given-names>S</given-names></name>
<name><surname>Peters</surname><given-names>H</given-names></name>
<name><surname>Thierfelder</surname><given-names>L</given-names></name>
</person-group>. <article-title>Heart failure in arrhythmogenic right ventricular dysplasia-cardiomyopathy</article-title>. <source>Int J Cardiol</source> <year>1999</year>; <volume>71</volume>: <fpage>251</fpage>–<lpage>256</lpage>.</citation>
</ref>
<ref id="bibr7-2048872612453922">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marcus</surname><given-names>FI</given-names></name>
<name><surname>Fontaine</surname><given-names>G</given-names></name>
</person-group>. <article-title>Arrhythmogenic right ventricular dysplasia/cardiomyopathy: a review</article-title>. <source>Pacing Clin Electrophysiol</source> <year>1995</year>; <volume>18</volume>: <fpage>1298</fpage>–<lpage>1314</lpage>.</citation>
</ref>
<ref id="bibr8-2048872612453922">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marcus</surname><given-names>FI</given-names></name>
</person-group>. <article-title>Prevalence of T-wave inversion beyond V1 in young normal individuals and usefulness for the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia</article-title>. <source>Am J Cardiol</source> <year>2005</year>; <volume>95</volume>: <fpage>1070</fpage>–<lpage>1071</lpage>.</citation>
</ref>
<ref id="bibr9-2048872612453922">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cox</surname><given-names>MG</given-names></name>
<name><surname>Nelen</surname><given-names>MR</given-names></name>
<name><surname>Wilde</surname><given-names>AA</given-names></name>
<etal/>
</person-group>. <article-title>Activation delay and VT parameters in arrhythmogenic right ventricular dysplasia/cardiomyopathy: toward improvement of diagnostic ECG criteria</article-title>. <source>J Cardiovasc Electrophysiol</source> <year>2008</year>; <volume>19</volume>: <fpage>775</fpage>–<lpage>781</lpage>.</citation>
</ref>
<ref id="bibr10-2048872612453922">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Willems</surname><given-names>JL</given-names></name>
<name><surname>Robles</surname><given-names>de</given-names></name>
<name><surname>Medina</surname><given-names>EO</given-names></name>
<name><surname>Bernard</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>Criteria for intraventricular conduction disturbances and pre-excitation: World Health Organizational/International Society and Federation for Cardiology Task Force Ad Hoc</article-title>. <source>J Am Coll Cardiol</source> <year>1985</year>; <volume>5</volume>: <fpage>1261</fpage>–<lpage>1275</lpage>.</citation>
</ref></ref-list>
</back>
</article>